retatrutide trial update october 2025 Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio Retatrutide Phase 3: TRIUMPH Program

It has been shown to reduce oxidative stress and improve cognitive function in patients with these conditions

As GLP-1 medication use continues to grow across the country, sweets and snacks are the most affected, explained Leigh Newland ODonnell, head of shopper and category insights at Kantar Retail North America during her session GLP-1 and how it may disrupt your brand.' The prevalence of GLP-1s is expected to impact $6bn in uneaten food sales this year with 46% of users reporting they intend to make better food choices and 43% who said they are overeating less, ODonnell said, citing results from Kantars GLP-1 syndicated study

(2024, October 17)

Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells